Nestle shares at two-year low as investors weigh Wegovy rollout
Reuters
Published Oct 06, 2023 05:41AM ET
(Reuters) - Nestle shares were under pressure on Friday as investors weighed the potential impact of Novo Nordisk (NYSE:NVO)'s blockbuster weight-losing drug Wegovy and how it could reduce spending on food.
The KitKat and Nescafe coffee maker's shares were down 2% and headed for their lowest level in more than two years. The pan-European food, beverage, and tobacco index fell 1.7%.
Nestle declined to comment on the stock performance. Peers Danone and Unilever (LON:ULVR) were also down, 1.5% and 2% lower respectively.
"I think it comes after Walmart (NYSE:WMT)'s comments regarding the impact on weight loss drug consumers perhaps buying less," the head of European consumer equities at Kepler Cheuvreux, Jon Cox, said.
Walmart's U.S. branch CEO John Furner told Bloomberg on Wednesday that the company saw a slight pullback in food consumption with people taking appetite-surpressing drugs such as Wegovy.
However, Cox does not regard this as a substantial risk to Nestle and the broader food industry in the long term.
Bruno Monteyne from Bernstein also pointed to the Wegovy impact, but saw little logic in the sell-off.
"Danone sells water, baby milk powder, and yogurt: not sure how those would be negatively impacted by GLP1 / Wegovy?" he said, referring to a broader class of drugs.
Vontobel analysts also only see limited risks for some categories of Nestle's products.
"We see some potential risks in some of the company’s product categories, such as frozen food in the US or confectionery, but less so in the other key categories, such as coffee, pet food, infant nutrition, culinary, water, or Nestlé Health Science," they wrote a note.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.